Use of a glycolipid inhibitor to ameliorate renal cancer in a mouse model.
In a xenograft model wherein, live renal cancer cells were implanted under the kidney capsule in mice, revealed a 30-fold increase in tumor volume over a period of 26 days and this was accompanied with a 32-fold increase in the level of lactosylceramide (LacCer). Mice fed D- threo-1-phenyl-2-decanoy...
Saved in:
Main Authors: | Subroto Chatterjee, Nezar Alsaeedi, Jennifer Hou, Veera Venkata Ratnam Bandaru, Lan Wu, Marc K Halushka, Roberto Pili, Georges Ndikuyeze, Norman J Haughey |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/57d8c0665a9c4073b4e5fa2fe80c1ac4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glycolipid-dependent and lectin-driven transcytosis in mouse enterocytes
by: Alena Ivashenka, et al.
Published: (2021) -
Unravelling the structural complexity of glycolipids with cryogenic infrared spectroscopy
by: Carla Kirschbaum, et al.
Published: (2021) -
Interplay of Trans- and Cis-Interactions of Glycolipids in Membrane Adhesion
by: Batuhan Kav, et al.
Published: (2021) -
Artemether Regulates Metaflammation to Improve Glycolipid Metabolism in db/db Mice
by: Fu W, et al.
Published: (2020) -
Identification of the ESKAPE pathogens by mass spectrometric analysis of microbial membrane glycolipids
by: Lisa M. Leung, et al.
Published: (2017)